Share
- Release Date: 02/08/12 15:34
- Summary: NTA: MLN: MLN NAV $0.8459 as at 31/7/12
- Price Sensitive: No
- Download Document 1.54KB
MLN
02/08/2012 13:34
NTA
REL: 1334 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8459 as at 31/7/12
MLN NAV $0.8459 as at 31/7/12
Date 31/7/2012 24/7/2012
MLN NAV $0.8459 $0.8613
Share price close $0.72 $0.72
Discount 15% 16%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 31 July 2012 are approximately as
follows:
Biotest (Germany) 6%
Sarin Technologies (Israel) 5%
Orthofix (United States) 4%
Stratec Biomedical (Germany) 4%
Wasion Group (China) 4%
NB: One of Marlin Global's investments, Fook Woo Group Holdings Limited
("Fook Woo") has voluntarily suspended its
trading on the Hong Kong stock exchange since 28 November 2011. The value of
Marlin Global's holding in Fook Woo
has been written down by 80%. Fook Woo comprises 1% of the portfolio as at
the date of this NAV announcement.
BACKGROUND
Marlin Global Limited is a listed investment company investing in smaller
companies that are listed on an approved stock exchange (excluding a stock
exchange in New Zealand or Australia). The investment portfolio is managed by
Fisher Funds Management Limited, a specialist New Zealand investment manager
with a track record of successfully investing in smaller company shares.
Marlin Global Limited began operating in November 2007 when it allotted
103,000,000 shares.
For further information please contact Marlin Global Limited, ph (09) 484
0365
End CA:00225593 For:MLN Type:NTA Time:2012-08-02 13:34:23
